3136 results for «358»
3136 results
EuroPCR 2021 - Innovations in stents & scaffolds
18 May 2021 – From EuroPCR 2021
This session will enable you to find out more about arterial balloon with variable pressures, SPAS (stent positioning assistance systems), thrombectomy with a novel stent retriever in patients with large thrombus burden, and bionanosensored stents.
EuroPCR 2021 - Innovations in bifurcation lesions
18 May 2021 – From EuroPCR 2021
This session will show you that in two-stent techniques, superior image quality may optimize precise stent placement, and that bifurcation stent for short left main artery can be made in cath lab.
EuroPCR 2021 - Innovations in stable CAD
18 May 2021 – From EuroPCR 2021
In this session, consider the accuracy of OFR in assessing stenting result and residual disease, appraise a novel hybrid IVUS-OCT catheter system, and question whether NOCAD/INOCA patients could be diagnosed with a new physiological wire by obtaining pressure-derived CFR.
PCR Peripheral for beginners - Femoro popliteal angioplasty
Watch this episode if you want to:
- Know where we are regarding paclitataxel controversy,
- Know how to deal with simple superficial artery case angioplasty,
- Discuss when to perform controlateral and antegrade accesses,
- Learn when to go intra luminal or sub intimal,
- Know how to select the best tools to use...
PCR Clinical Research 2021 - Waiting for EBC-MAIN, a randomised trial of stenting strategies for the treatment of LM coronary bifurcation disease
28 Apr 2021 – From EuroPCR 2021
How are you going to treat your next left main lesion involving both LAD and CX ostia: provisional vs. upfront two-stent strategy ? Follow this PCR Clinical Research episode for more news on the EBC MAIN trial!
PCR Clinical Research - Late breaking science at EuroPCR 2021:...
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
EuroPCR 2021 - Innovations in mitral valve replacement and repair
18 May 2021 – From EuroPCR 2021
In this session, get a clear presentation of the SATURN device, its procedure and its early results, and a good demonstration of the successful transseptal deployment of this implant in the acute porcine model.
EuroPCR 2021 - Innovations in chronic heart failure
18 May 2021 – From EuroPCR 2021
This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.
Challenging Left Main Cases
18 May 2021 – From EuroPCR 2021
Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...
A young patient with excruciating chest pain and extensive complications
18 May 2021 – From EuroPCR 2021
Try to find out what happens to the presented patient, only 34 years old: spasm, ACS, STEMI occluded diagonal culprit lesion, or spontaneous dissection causing occlusion of diagonal branch? And ask yourself what you would do in such a case!
Exclusion of a huge symptomatic coronary-cameral fistulae
18 May 2021 – From EuroPCR 2021
In this session, find out more about CCF, a rare but major congenital anomaly with potential serious complications undergoing in the older patients.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
